Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment

被引:0
|
作者
Daniel, WA
Syrek, M
Mach, A
Wojcikowski, J
Boksa, J
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Pharmacokinet & Drug Metab, PL-31343 Krakow, Poland
[2] Polish Acad Sci, Inst Pharmacol, Dept Drug Chem, PL-31343 Krakow, Poland
来源
POLISH JOURNAL OF PHARMACOLOGY | 1997年 / 49卷 / 06期
关键词
pharmacokinetics; plasma; brain; thioridazine; mesoridazine; sulforidazine; N-desmethylthioridazine; ring sulfoxide;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was aimed at investigation of the pharmacokinetics of thioridazine and its metabolites after a single and repeated administrations. Male Wistar rats received thioridazine as a single dose (10 mg/kg ip) or they were treated chronically with the neuroleptic (10 mg/kg ip, twice a day for two weeks). Plasma and brain concentrations of thioridazine and its metabolites (N-desmethylthioridazine, mesoridazine, sulforidazine, and the ring sulfoxide) were determined using the HPLC method. The obtained data showed that sulfoxidation in position 2 of the thiomethyl substituent and in the thiazine ring are main metabolic pathways of thioridazine, and showed that, in contrast to humans, in the rat N-desmethylthioridazine is formed in appreciable amount. The biotransformation of thioridazine was rather fast yielding plasma peak concentrations of metabolites lower than that of the parent compound. The maximum concentrations of thioridazine and its metabolites in the brain appeared later than in plasma. The peak concentrations and AUC values of thioridazine and its metabolites were higher in the brain than in plasma and this corresponded well with their longer half-lives in the brain as compared to plasma. The drug was not taken up by the brain as efficiently as other phenothiazines, Chronic treatment with thioridazine produced significant increases (with the exception of thioridazine ring sulfoxide) in the plasma concentrations of the parent compound and its metabolites which was accompanied with the prolongation of their plasma half-lives. The observed plasma levels of thioridazine were within 'therapeutic range' while the concentrations of its metabolites were relatively lower as compared to those observed in psychiatric patients. The increased plasma concentrations of thioridazine and its metabolites observed in plasma after chronic treatment were not followed by parallel changes in the brain.
引用
收藏
页码:439 / 452
页数:14
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF AMITRIPTYLINE AND ITS DEMETHYLATED METABOLITE IN SERUM AND SPECIFIC BRAIN-REGIONS OF RATS AFTER ACUTE AND CHRONIC ADMINISTRATION OF AMITRIPTYLINE
    MIYAKE, K
    FUKUCHI, H
    KITAURA, T
    KIMURA, M
    SARAI, K
    NAKAHARA, T
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (04) : 288 - 291
  • [22] PHARMACOKINETICS OF MAPROTILINE AND ITS DEMETHYLATED METABOLITE IN SERUM AND SPECIFIC BRAIN-REGIONS OF RATS AFTER ACUTE AND CHRONIC ADMINISTRATION OF MAPROTILINE
    MIYAKE, K
    FUKUCHI, H
    KITAURA, T
    KIMURA, M
    KIMURA, Y
    NAKAHARA, T
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (12) : 1114 - 1118
  • [23] Pharmacokinetics of mequindox and its metabolites in rats after intravenous and oral administration
    Li, Guanghui
    Yang, Fan
    He, Limin
    Ding, Huanzhong
    Sun, Na
    Liu, Yingchun
    Liu, Yiming
    Shan, Qi
    Li, Yafei
    Zeng, Zhenling
    RESEARCH IN VETERINARY SCIENCE, 2012, 93 (03) : 1380 - 1386
  • [24] MICE PLASMA AND BRAIN PHARMACOKINETICS OF AMITRIPTYLINE AND ITS DEMETHYLATED AND HYDROXYLATED METABOLITES AFTER HALF-LIFE REPEATED ADMINISTRATION - COMPARISON WITH ACUTE ADMINISTRATION
    COUDORE, F
    FIALIP, J
    ESCHALIER, A
    LAVARENNE, J
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (06) : 525 - 531
  • [25] Pharmacokinetics and brain dispositions of tacrine and its major bioactive monohydroxylated metabolites in rats
    Qian, Shuai
    Wo, Siu Kwan
    Zuo, Zhong
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 61 : 57 - 63
  • [26] Pharmacokinetics of Mephedrone and Its Metabolites in Whole Blood and Plasma after Controlled Intranasal Administration to Healthy Human Volunteers
    Czerwinska, Joanna
    Parkin, Mark C.
    George, Claire
    Kicman, Andrew T.
    Dargan, Paul, I
    Abbate, Vincenzo
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2021, 45 (07) : 730 - 738
  • [27] ACUTE AND CHRONIC ETHANOL INDUCED ALTERATIONS IN BRAIN NOREPINEPHRINE METABOLITES IN RATS
    THADANI, PV
    KULIG, BM
    BROWN, FC
    BEARD, JD
    PHARMACOLOGIST, 1974, 16 (02): : 304 - 304
  • [28] EFFECT OF PHENOBARBITAL ON CARBAMAZEPINE AND ITS MAJOR METABOLITES IN SERUM, DIFFERENT BRAIN-AREAS, AND URINE AFTER ACUTE AND CHRONIC ADMINISTRATION TO RATS
    MENDEZALVAREZ, E
    SOTOOTERO, R
    GALANVALIENTE, J
    SIERRAMARCUNO, G
    EPILEPSIA, 1990, 31 (02) : 202 - 210
  • [29] DISTRIBUTION OF PHENAZEPAM-C-14 AND ITS METABOLITES IN THE LIVER, BRAIN AND BLOOD-PLASMA AT A SINGLE AND CHRONIC ADMINISTRATION TO ALBINO-RATS
    GOLOVENKO, NY
    ZINKOVSKY, VG
    SEREDENIN, SB
    ANDRONATI, SA
    YAKUBOVSKAYA, LN
    FARMAKOLOGIYA I TOKSIKOLOGIYA, 1980, 43 (02): : 144 - 148
  • [30] PHARMACOKINETICS OF CAFFEINE AND ITS METABOLITES IN PREGNANT RATS
    NAKAZAWA, K
    TANAKA, H
    ARIMA, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 36 : P76 - P76